Effect of lower calcium dialysate on laboratory abnormalities in chronic kidney disease-associated mineral and bone

Anip Bansal1, Gagangeet Sandhu, Rohit A Chitale

  • 1Division of Nephrology, Department of Medicine, St Luke's-Roosevelt Hospital Center, New York, NY 10025, USA.

Insights

Lowering dialysate calcium in hemodialysis significantly reduced serum calcium levels. This intervention did not increase parathyroid hormone or vitamin D analog requirements, offering a potential strategy to reduce vascular calcification risk in end-stage renal disease patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Vascular calcification, linked to cardiovascular disease in end-stage renal disease (ESRD) patients, is often associated with excess calcium (Ca) and phosphate.
  • Lowering dialysate Ca concentration is a proposed method to prevent long-term Ca accumulation.

Purpose of the Study:

  • To investigate the impact of decreasing dialysate Ca concentration on serum Ca levels, parathyroid hormone (PTH), and medication requirements in maintenance hemodialysis patients.
  • To evaluate the feasibility of reducing total Ca load in ESRD patients undergoing hemodialysis.

Main Methods:

  • A single outpatient dialysis center reduced standard dialysate Ca concentration from 2.5 to 2.25 mEq/L in September 2009.
  • Serum Ca and intact parathyroid hormone (iPTH) levels were monitored in maintenance hemodialysis patients.

Main Results:

  • A significant reduction in mean serum Ca concentration was observed after lowering the dialysate Ca.
  • No significant increase in serum parathyroid hormone levels was detected.
  • There was no increase in the requirement for vitamin D analogs or Ca-based phosphate binders.

Conclusions:

  • Reducing dialysate Ca concentration in maintenance hemodialysis is effective in lowering serum Ca without adversely affecting PTH levels or medication needs.
  • This intervention shows promise for decreasing the overall Ca load in ESRD patients.
  • Further research is warranted to determine the long-term effects on cardiovascular morbidity and mortality.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...